rs879255652
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001330260.2(SCN8A):c.4447G>A(p.Glu1483Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1483D) has been classified as Uncertain significance.
Frequency
Consequence
NM_001330260.2 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 13Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- cognitive impairment with or without cerebellar ataxiaInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- seizures, benign familial infantile, 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- benign familial infantile epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile convulsions and choreoathetosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myoclonus, familial, 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN8A | NM_001330260.2 | c.4447G>A | p.Glu1483Lys | missense_variant | Exon 25 of 27 | ENST00000627620.5 | NP_001317189.1 | |
SCN8A | NM_014191.4 | c.4447G>A | p.Glu1483Lys | missense_variant | Exon 25 of 27 | ENST00000354534.11 | NP_055006.1 | |
SCN8A | NM_001177984.3 | c.4324G>A | p.Glu1442Lys | missense_variant | Exon 24 of 26 | NP_001171455.1 | ||
SCN8A | NM_001369788.1 | c.4324G>A | p.Glu1442Lys | missense_variant | Exon 24 of 26 | NP_001356717.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN8A | ENST00000354534.11 | c.4447G>A | p.Glu1483Lys | missense_variant | Exon 25 of 27 | 1 | NM_014191.4 | ENSP00000346534.4 | ||
SCN8A | ENST00000627620.5 | c.4447G>A | p.Glu1483Lys | missense_variant | Exon 25 of 27 | 5 | NM_001330260.2 | ENSP00000487583.2 | ||
SCN8A | ENST00000599343.5 | c.4480G>A | p.Glu1494Lys | missense_variant | Exon 24 of 26 | 5 | ENSP00000476447.3 | |||
SCN8A | ENST00000355133.7 | c.4324G>A | p.Glu1442Lys | missense_variant | Exon 23 of 25 | 1 | ENSP00000347255.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1456062Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 724174
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Seizures, benign familial infantile, 5 Pathogenic:4
- -
- -
PM2_Supporting+PS3_Moderate+PP2+PS4_Moderate+PP1_Strong+PP4 -
- -
Developmental and epileptic encephalopathy, 13 Pathogenic:1Other:1
- -
Variant summary: SCN8A c.4447G>A (p.Glu1483Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 243750 control chromosomes (gnomAD). c.4447G>A has been reported in the literature in multiple individuals affected with benign infantile seizures and/or paroxysmal dyskinesia (e.g. Gardella_2016). These data indicate that the variant is very likely to be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 26677014). ClinVar contains an entry for this variant (Variation ID: 253195). Based on the evidence outlined above, the variant was classified as pathogenic. -
Developmental and epileptic encephalopathy Pathogenic:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1483 of the SCN8A protein (p.Glu1483Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of SCN8A-related conditions (PMID: 26677014, 30185235). It has also been observed to segregate with disease in related individuals. This variant is also known as p.E1442K. ClinVar contains an entry for this variant (Variation ID: 253195). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SCN8A protein function with a positive predictive value of 95%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on SCN8A function (PMID: 30615093). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Published functional studies demonstrate a damaging effect indicating that the E1483K variant alters sodium channel properties (Liu et al., 2019); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed in large population cohorts (gnomAD); Missense variants in this gene are often considered pathogenic (HGMD); This variant is associated with the following publications: (PMID: 32090326, 30615093, 27210545, 27270488, 26677014, 30185235, 29263050, 31904124, 26029160) -
Epilepsy Pathogenic:1
The variant chr12-52184209-G-A, SCN8A(NM_014191.4):c.4447G>A,p.(Glu1483Lys) was identified in an individual with Epilepsy. Inheritance was maternal (heterozygous). The variant was reviewed according to current ACMG recommendations and classified as Pathogenic (criteria: PP1_Strong, PS3_Moderate, PS4_Moderate, PM2_Supporting, PP3_Supporting). -
Seizure Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at